CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference CURE Pharmaceutical Holding Corp (CURE or the Company) (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Companys Chief Executive Officer Rob Davidson will be presenting at the H.C. Wainwright BioConnect 2021 Virtual Conference being held January 11-14. The presentation can be viewed beginning at 6:00 a.m. EST on January 11, 2021, and can be accessed here through registration and will be available online until January 14.